GM-CSF counteracts hemorrhage-induced suppression of cytokine-producing capacity

Inflammation Research

Volumn 53, Issue 1, 2004, Pages 13-21

  Husain, B ^a   Lendemans, S ^a   Ackermann, M ^a   Wendel, A ^b   Schade, F U ^a   Flohe S ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c NONE

Author keywords

Endotoxin; GM CSF; Hemorrhage; Immuno suppression; TNF

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; LIPOPOLYSACCHARIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CULTURE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HEMORRHAGIC SHOCK; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; RESUSCITATION; SPLEEN CELL;

ANIMALS; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642471678     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1216-2     Document Type: Article

References (43)

1. Majetschak M, Flach R, Heukamp T et al. Regulation of whole blood Tumour Necrosis Factor production upon endotoxin stimulation after severe blunt trauma. J Trauma 1997; 43: 1-8.
2. Ertel W, Morrison MH, Meldrum DR, Ayala A, Chaudry IH. Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1992; 53: 55-61.
3. Mendez C, Jaffray C, Wong V et al. Involvement of p38 mitogen-activated protein kinase in the induction of tolerance to hemorrhagic and endotoxic shock. J Surg Res 2000; 92: 165-70.
4. Faist E, Ertel W, Baker CC, Heberer G. Terminal B-cell maturation and immunoglobulin (Ig) synthesis in vitro in patients with major injury. J Trauma 1989; 29: 2-9.
5. Faist E, Schinkel C, Zimmer S, Kremer JP, von Donnersmarck GH, Schildberg FW. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 1993; 34: 846-53.
6. Rhee P, Waxman K, Clark L et al. Tumor necrosis factor and monocytes are released during hemorrhagic shock. Resuscitation 1993; 25: 249-55.
7. Beutler B, Milsark I, Cerami A. Passive immunization against Cachectin/TNF protects mice from lethal effects of endotoxin. Science 1985; 229: 869-71.
8. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, Schlag G. Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1997; 272: H2219-6.
9. Zentella A, Manogue K, Cerami A. The role of cachectin/TNF and other cytokines in sepsis. Prog Clin Biol Res 1991; 367: 9-24.
10. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 452.
11. Pfeffer K, Matsuyama T, Kundig TM et al. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L.monocytogenes infection. Cell 1993; 73: 457-67.
12. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-72.
13. Rapoport AP, Abboud CN, DiPersio JF. Granulocyte-acrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Rev 1992; 6: 43-57.
14. Hayes MP, Freeman SL, Donnelly RP. IFN-gamma priming of monocytes enhances LPS-induced TNFα production by augmenting both transcription and mRNA stability. Cytokine 1995; 7: 427-35.
15. Williams MA, Kelsey SM, Collins PW, Gutteridge CN, Newland AC. Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy. Br J Haematol 1995; 90: 31-40.
16. DiPersio JF, Billing P, Williams R, Gasson JC. Human granulocyte- macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis. J Immunol 1988; 140: 4315-22.
17. Sullivan R, Griffin JD, Simons ER et al. Effects of recombinant human Granulocyte and Macrophage Colony-Stimulating Factors on signal transduction pathways in human granulocytes. J Immunol 1987; 139: 3422-30.
18. Randow F, Doecke WD, Bundschuh DS, Hartung T, Wendel A, Volk HD. In vitro prevention and reversal of lipopolysaccharide desensitization by IFNγ, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol 1997; 158: 2911-8.
19. Lieschke GJ, Burgees AW. Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor. N Engl J Med 1992; 327: 28-35.
20. Bilgin K, Yaramis A, Haspolat K, Tas A, Günbey S, Derman O. (2001) A randomized trial of Granulocyte-Macrophage Colony-stimulating Factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107: 36-41.
21. Presneill J, Harris T, Stewart AG, Cade JF, Wilson JW. A randomized phase II trial of Granulocyte-Macrophage Colony-stimulating Factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002; 166: 138-43.
22. Flohé S, Boergermann J, Dominguez FE, et al. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis. Shock 1999; 12: 17-24.
23. Ackermann M, Reuter M, Flohé S, Bahrami S, Redl H, Schade F.U. Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J Endotox Res 2001; 7: 105-12.
24. Kramer AA, Salhab KF, Shafii AE, Norman J, Carey LC, Mendez C. Induction of tolerance to hemorrhagic or endotoxic shock involves activation of NF-kappaB. J Surg Res 1999; 83: 89-94.
25. Schroeder J, Kahlke V, Faendrich F, Zabel P, Kremer B. Tumor necrosis factor-alpha hyporesponsiveness of rat intestinal cells and portal venous blood after hemorrhagic shock. Crit Care Med 1998; 26: 526-32.
26. Flohé S, Ackermann M, Reuter M, Nast-Kolb D, Schade FU. Sublethal hemorrhagic shock reduces tumor necrosis factor-a-producing capacity in different cell compartments. Eur Cytokine Netw 2000; 11: 420-26.
27. Zervos EE, Kramer AA, Salhab KF, Norman JG, Carey LC, Rosemurgy AS. Sublethal hemorrhage blunts the inflammatory cytokine response to endotoxin in a rat model. J Trauma 1999; 46: 145-9.
28. Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 1996; 157: 5748-54.
29. Ertel W, Morrison MH, Ayala A, Chaudry IH. Insights into the mechanisms of defective antigen presentation after hemorrhage. Surgery 1991; 110: 440-5.
30. Ayala A, Perrin MM, Ertel W, Chaudry IH. Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 1992; 4: 66-75.
31. Nwariaku FE, McIntyre KL, Sikes PJ, Mileski WJ. Alterations in alveolar macrophage tumor necrosis factor (TNF) response following hemorrhagic shock. Shock 1995; 4: 200-3.
32. Naziri W, Pietsch JD, Appel SH, Cheadle WG, Bergamini TM, Polk HC Jr. Hemorrhagic shock-induced alterations in circulating and bronchoalveolar macrophage nitric oxide production. J Surg Res 1995; 59: 146-52.
33. Flach R, Majetschak M, Heukamp T et al. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 1999; 11: 173-8.
34. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC. Depressed Interferon Gamma Production and Monocyte HLA-DR Expression after Severe Injury Arch Surg 1988; 123: 1309-12.
35. Mayer P, Lam C, Obenaus H, Liehl E, Besemer J. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. Blood 1987; 70: 206-13.
36. Hayes MP, Enterline JC, Gerrard TL, Zoon KC. Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide- induced production. J Leukoc Biol 1991; 50: 176-81.
37. Hartung T. Immunomodulation by colony-stimulating factors. Rev Physiol Biochem Pharmacol 1999; 136: 1-164.
38. Adib-Conquy M, Cavaillon JM. Gamma Interferon and Granulocyte/Monocyte Colony-stimulating Factor prevent Endotoxin Tolerance in human monocytes by promoting Interleukin-1 Receptor-associated Kinase Expression and its association to MyD88 and not by modulating TLR4 Expression J Biol Chem 2002; 277: 27927-34.
39. Randow F, Syrbe U, Meisel C et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181: 1887-92.
40. Spagnoli GC, Juretic A, Rosso R, Van Bree J, Harder F, Heberer M. Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol 1995; 43: 45-50.
41. Austin OM, Redmond HP, Watson WG, Cunney RJ, Grace PA, Bouchier Hayes D. The beneficial effects of immunostimulation in posttraumatic sepsis. J Surg Res 1995; 59: 446-9.
42. Sun H, Wu X, Qian X et al. Posttraumatic expression of MHC II molecules: an experimental and clinical study. Chin J Traumatol 2000; 3: 50-2.
43. Vial T, Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf 1995; 13: 371-406.